[Summary] Experts in global pharmaceutical and healthcare
Yifan Pharmaceutical Co., Ltd. is a company listed on the Shenzhen Stock Exchange A-share market, with the securities abbreviation: Yifan Pharma, and securities code: 002019. The company is an innovative pharmaceutical R&D and manufacturing enterprise, hosting Yifan Research Institute, a provincial-level enterprise technology center (R&D center), and several high-tech enterprises under its umbrella. It employs over a hundred masters and doctors in pharmacy and related fields, and has two advanced biologics innovation platforms: bispecific antibody technology and immune antibody technology. The company has obtained nearly a hundred domestic and international pharmaceutical-related patents, including 35 international patents. It has undertaken national projects such as the 'Tenth Five-Year' key technologies R&D program, the national high-tech industrialization demonstration project, and the National Torch Plan, and has won one National Invention Award (Second Prize) and one National Science and Technology Progress Award (Second Prize). The company is oriented towards professional, specialty, and therapeutic key specialty areas, continuously innovating and transforming, focusing on high-molecular biologics, high-end chemical drugs, and distinctive traditional Chinese medicine. It has dozens of high-end chemical drugs in development, with nearly 10 in clinical or filing stages; and holds over 400 drug approval numbers for gynecology, pediatrics, dermatology, among others. It currently has several large-molecule biologics in international Phase II and III clinical trials, making it a Chinese enterprise that has advanced to Phase II and III clinical trials in the United States for innovative biologics, leading Chinese biologics to knock on the door of the US market. The company has established production centers: Anhui as the main center for small-molecule high-end chemical drugs and botanical drugs; Sichuan for dermatology and gynecology; Liaoning for orthopedics and therapeutic large-volume infusions; Beijing and Shanghai for large-molecule biologics R&D and production; and Zhejiang for APIs. The company's pharmaceutical business covers all provinces and municipalities except Hong Kong, Macao, and Taiwan, with over 60% coverage of pharmaceutical preparations in secondary hospitals and above nationwide. Meanwhile, as one of the world's largest suppliers of vitamin B5 and panthenol, its medical API sales network extends to various countries and regions in Europe and the Americas, holding a 40%-45% global market share. Looking forward, the company will continue to focus on pharmaceutical and healthcare, adhere to the development strategy of 'integration, innovation, and internationalization', uphold the core values of 'pragmatism, innovation, integrity, and diligence', and commit to creating value for customers, platforms for employees, wealth for shareholders, and value for society, growing into a global expert in pharmaceutical and healthcare.
What does Yifan Pharmaceutical Co., Ltd. require? Who is Yifan Pharma hiring? Yifan Pharma recruitment: 市场/公关/媒介类占比最多占45.9%，其次是销售类占28.7%. What education can get in at Yifan Pharma? 大专占比最多占62.4%，其次是本科占29.7%. High education required at Yifan Pharma? 硕士占3.8%，博士占1.3%. Work experience required at Yifan Pharma? 1-3年占比最多占56.4%，其次是不限占18.6%. Where are the job locations at Yifan Pharma? 合肥占比最多占13%，其次是上海占8.6%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
